Does uterine cancer affect pregnancy in women?

Does female uterine cancer affect pregnancy? Giving birth is a wonderful experience for female friends, but the emergence of diseases has made many women lose the qualification to be mothers. The most fatal blow is undoubtedly the occurrence of uterine cancer. The uterus is the only place to give birth to a baby. If the uterus is diseased, the consequences can be imagined. So, does female uterine cancer affect pregnancy?

If early uterine cancer is discovered in time, patients can receive conservative treatment and regular follow-up to create opportunities for normal conception. However, if the disease develops to the late stage, reproduction is impossible. If uterine cancer is diagnosed after pregnancy, it is generally recommended to terminate the pregnancy in order to protect the mother.

Uterine cancer is a common cancer in the female reproductive system, ranking fourth among the most common cancers in women. It is more common in women aged 50 to 60, and often occurs after menopause. The incidence rate has been increasing worldwide in recent years. It can metastasize to many parts of the body: from the uterus downward to the cervical canal, from the fallopian tube upward to the ovary, and can also infiltrate the tissues around the uterus, or metastasize to areas far away from the uterus through the lymphatic system and blood circulation.

There are no obvious symptoms in the very early stage, but vaginal bleeding, vaginal discharge, pain, etc. will appear later. Vaginal bleeding is mainly postmenopausal vaginal bleeding, and the amount is generally not much. Those who have not yet reached menopause may experience increased menstruation, prolonged menstruation, or menstrual disorders. Vaginal discharge is mostly bloody liquid or serous secretions. If combined with infection, there will be purulent and bloody discharge with a foul odor.

Chemotherapy is one of the comprehensive treatment measures for advanced or recurrent uterine cancer. It can also be used to treat patients with high-risk factors for recurrence after surgery in order to reduce distant metastasis outside the pelvis. Commonly used chemotherapy drugs include cisplatin, doxorubicin, paclitaxel, cyclophosphamide, fluorouracil, mitomycin, etoposide, etc. It can be used alone or in combination, and can also be used in combination with progesterone. Chemotherapy should be given after surgery for uterine papillary serous adenocarcinoma, and the regimen is the same as that for ovarian epithelial cancer.

For the prevention measures of diseases such as uterine cancer, we must actively popularize cancer prevention knowledge, have regular physical examinations, pay attention to the diagnosis and treatment of vaginal bleeding in postmenopausal women and menstrual disorders in perimenopausal women, correctly master the indications and methods of estrogen application, and closely follow up or monitor people with high-risk factors.